Balance Wealth’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
Balance Wealth's ACAD Position: Q3 2026 in Review
Balance Wealth opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 105 shares worth $2.12K. The stake represents ﹤0.01% of the portfolio and ranks #756 among its holdings.
350 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Balance Wealth held 105 shares of Acadia Pharmaceuticals worth $2.12K as of Q3 2026.
- Acadia Pharmaceuticals was a new Balance Wealth position in Q3 2026.
- Acadia Pharmaceuticals made up ﹤0.01% of Balance Wealth's portfolio in Q3 2026, its #756 holding.
- 350 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Balance Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.